Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) Short Interest Update

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) was the recipient of a significant drop in short interest in March. As of March 15th, there was short interest totalling 541,500 shares, a drop of 47.9% from the February 28th total of 1,039,200 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is presently 5,415.0 days. Approximately 0.3% of the company’s stock are sold short.

Recordati Industria Chimica e Farmaceutica Price Performance

Shares of OTCMKTS:RCDTF remained flat at $55.54 during trading on Friday. Recordati Industria Chimica e Farmaceutica has a one year low of $52.25 and a one year high of $52.25. The firm has a market capitalization of $11.46 billion, a price-to-earnings ratio of 27.77 and a beta of 0.30. The firm has a fifty day simple moving average of $55.54 and a 200 day simple moving average of $53.72.

About Recordati Industria Chimica e Farmaceutica

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.